GlassScriptPhysician profile
Faraz Khan
NPI 1770087850
$4,674.51
in general payments reported to CMS, 2019-2025
8 companies · $2,534 in 2025
The $2,534 reported for 2025 was more than what 78% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $2,140 · 2025: $2,534.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,200 · Travel and Lodging: $1,347 · Food and Beverage: $1,128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,200.00 |
| Travel and Lodging | $1,346.81 |
| Food and Beverage | $1,127.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $2,539.89 | 2024-2025 | Progreat, Angio-Seal, Azur Cx Detachable |
| Penumbra, INC. | $1,568.66 | 2024 | Indigo System |
| Boston Scientific Corporation | $211.15 | 2024 | Eluvia, Carotid Wallstent |
| Inari Medical, INC. | $180.42 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Bioprotect Medical, INC. | $64.92 | 2024-2025 | Bioprotect Balloon Implant System |
| Angiodynamics, INC. | $57.66 | 2024 | Micro Access |
| Siemens Medical Solutions USA, INC. | $30.58 | 2024 | Embozene |
| Sumitomo Pharma America, INC. | $21.23 | 2025 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Faraz Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.